Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation

NCT03198741 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

783

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Injury
Ischemic Heart Disease

Interventions

DRUG: Aspirin + clopidogrel
DRUG: Clopidogrel monotherapy
DRUG: Aspirin monotherapy

Sponsor

Shenyang Northern Hospital

Collaborators

[object Object]
[object Object]